Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
NEW YORK Pfizer brands at Bates worth a total of $260 million are shifting to WPP Group’s J. Walter Thompson, where they will be housed in a new division called, Health@JWT, an agency representative said.
The shift, which was expected [Adweek, July 28], follows last week’s close of WPP’s deal to buy Bates parent Cordiant Communications Group.
The incoming brands, which include Benadryl, Neosporin, Rolaids and Visine, join some $200 million worth of Pfizer business already at JWT, including Listerine, Efferdent and Tucks.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in